(firstQuint)Effect on Metabolic Parameters of Abilify in SPR.

 To measure the long-term changes in weight, plasma lipids and fasting blood glucose after switching antipsychotic treatment to aripiprazole, 1 year, open label studies in out and in-patients with schizophrenia.

 The measurement of weight and lipid profile and fasting blood glucose will be measured at baseline and every 3 months for 1 year.

.

 Effect on Metabolic Parameters of Abilify in SPR@highlight

To measure the long-term changes in weight and plasma lipids after switching antipsychotic treatment to aripiprazole